Lead Sponsor

HealthPartners Institute

Collaborators

Age

21 - 75 years

Sex

ALL

Healthy Volunteers

Yes

•Male or female
•Within normal range for two hour OGTT glucose level (\<140 mg/dl)
•Within normal range for fasting glucose level (\<100 mg/dl)
•Within normal range for total insulin level as measured by radioimmunoassay
•BMI \<30kg/m2
•Age 21-75 years of age, inclusive (15 subjects in the 21-49 years of age group, 15 subjects in the 50-75 years of age group)
•Willing to give informed consent
•Capable of following the protocol and instructions of study staff
•Available for scheduled visits
•Access to telephone communications

•Under 21 years of age or over 75 years of age
•Abnormal OGTT
•Previous history of diabetes
•Outside of normal insulin range
•BMI \> 30kg/m2
•Unable to follow protocol
•Unable to read and write in English
•Skin abnormalities at insertion sites
•Allergy to adhesives
•Any concomitant medical condition that would likely affect the evaluation of device performance
•Taken prednisone or cortisone medications in the previous 30 days
•Blood transfusion within the past 90 days
•Blood donation within the past 30 days
•Metabolic syndrome (NCEP ATP III guidelines)
•Any medical condition that would affect glucose (per investigator decision)

Related studies

NCT07061301 · Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Monitoring, and more

NCT07036757 · Food Insecurity, Dietary Quality, and more

NCT03981328 · Cgm, Gestational Diabetes, and more

NCT06226948 · Cardiovascular Diseases, Coronary Artery Disease, and more

NCT05460260 · Efficacy of a 21-Day Wear Period for the Cascade CGM

Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM Data